Literature DB >> 28823020

Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.

Shadi Saleh1, Clara Abou Samra2, Stewart Jleilaty2, Joanne Constantin2, Nour El Arnaout2, Hani Dimassi3, Dania Al-Bittar2.   

Abstract

Background Patients, physicians and pharmacists are key stakeholders in the implementation of generic substitution policies. Objectives To explore Lebanese patients' perceptions and experience, and pharmacists' dispensing patterns towards the newly enacted unified health prescription policy promoting generic substitution. Setting Pharmacies in Beirut, the capital of Lebanon. Methods A cross-sectional design employing self-administered questionnaires to survey a total of 128 patients and 25 pharmacists. Chi square test and multiple logistic regression were performed. Main outcome Perceptions and behaviors of patients and pharmacists towards the unified health prescription and generic substitution. Results Fourty-eight percent of the patients knew the definition of generic drugs, among which 59.0% perceived that generic drugs have the same effectiveness as their branded alternatives and 59.0% perceiving that generic drugs could reduce Lebanon's medical bill as well. Sixty-one percent of the patients were aware of the unified health prescription. Only 13.6% of the pharmacists suggested to patients to replace prescribed brand drug by a generic when their prescriptions were not marked with non-substitution. Conclusions Progress has been made with regards to enhancing generic substitution in the Lebanese healthcare field. However, it remains important to educate patients about generic medicines and plan context-specific schemes that promote prescribing and dispensing of generic drugs among physicians and pharmacists.

Entities:  

Keywords:  Access to medicine; Generic drugs; Health policy; Lebanon; Outpatients; Pharmacy

Mesh:

Substances:

Year:  2017        PMID: 28823020     DOI: 10.1007/s11096-017-0509-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  29 in total

1.  Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Authors:  Michael A Fischer; Jerry Avorn
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

2.  Generic drugs: international trends and policy developments in Australia.

Authors:  Hans Lofgren
Journal:  Aust Health Rev       Date:  2004       Impact factor: 1.990

3.  Patients' attitudes towards and experiences of generic drug substitution in Norway.

Authors:  Inge Kjoenniksen; Morten Lindbaek; Anne Gerd Granas
Journal:  Pharm World Sci       Date:  2006-11-17

4.  Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.

Authors:  Karolina Andersson; Gina Bergström; Max G Petzold; Anders Carlsten
Journal:  Health Policy       Date:  2006-09-01       Impact factor: 2.980

5.  Common prescriptions in ambulatory care in Lebanon.

Authors:  G N Hamadeh; L M Dickerson; B R Saab; S C Major
Journal:  Ann Pharmacother       Date:  2001-05       Impact factor: 3.154

6.  Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.

Authors:  P McManus; D J Birkett; J Dudley; A Stevens
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Jun-Jul       Impact factor: 2.890

7.  What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.

Authors:  Karolina Andersson; Christian Sonesson; Max Petzold; Anders Carlsten; Knut Lönnroth
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-05       Impact factor: 2.890

8.  People's views on the level of agreement of generic medicines for different illnesses.

Authors:  Maria João Figueiras; Dália Marcelino; Maria Armanda Cortes
Journal:  Pharm World Sci       Date:  2008-08-14

9.  Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?

Authors:  William H Shrank; Suzanne M Cadarette; Emily Cox; Michael A Fischer; Jyotsna Mehta; Alan M Brookhart; Jerry Avorn; Niteesh K Choudhry
Journal:  Med Care       Date:  2009-03       Impact factor: 2.983

Review 10.  Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review.

Authors:  Sarah Colgan; Kate Faasse; Leslie R Martin; Melika H Stephens; Andrew Grey; Keith J Petrie
Journal:  BMJ Open       Date:  2015-12-15       Impact factor: 2.692

View more
  3 in total

1.  Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities.

Authors:  Mohamad Alameddine; Karen Bou Karroum; Mohamad Ali Hijazi
Journal:  Hum Resour Health       Date:  2019-06-24

2.  Good pharmacy practice assessment among community pharmacies in Lebanon.

Authors:  Danielle A Badro; Hala Sacre; Souheil Hallit; Ali Amhaz; Pascale Salameh
Journal:  Pharm Pract (Granada)       Date:  2020-03-16

3.  Improving the availability of prescription drugs in Lebanon: a critical analysis of alternative policy options.

Authors:  Amena El-Harakeh; Sean J Haley
Journal:  Health Res Policy Syst       Date:  2022-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.